Frank Tagliaferri, Ph.D., Vice President of Pharmaceutical Development sat down with BioProcess International to discuss the growth the industry, and the growth of Pace® Life Sciences over the past few years. https://www.youtube.com/watch?v=t_w6Re3vZbU
Getting Drugs to Market – Dr Frank Tagliaferri, Pace Life Sciences Read More »
Frank Tagliaferri, Ph.D., VP of Pharmaceutical Development & GM Biocompare, The Buyer’s Guide for Life Sciences Published an Article: The Changing Landscape of Gene Therapy, written by Frank Tagliaferri, Ph.D., VP of Pharmaceutical Development & GM at Pace® Life Sciences (PLS). Read the full article
The Changing Landscape of Gene Therapy Read More »
Acquisition adds significant experience and expertise in the development of liquid, semi-solid, and oral solid dose products for pre-clinical and clinical use allowing Pace to support a growing number of clients throughout the drug development process. Minneapolis, MN, October 11, 2021 – Pace Analytical Life Sciences®, LLC, a subsidiary of Pace Analytical® Services, LLC, a full-service contract development
Pace® Life Sciences Acquires Velesco Pharmaceutical Services Read More »
Acquisition allows Pace to support a growing number of clients requiring services throughout the drug development process while adding expertise on drug-device combination products and extended-release injectable technologies. Pace Life Sciences Acquires Drug Delivery Experts, Expanding Capacity and Injectable Drug Product Services Minneapolis, MN, July 23, 2021 – Pace Analytical Life Sciences®, LLC, a subsidiary
The installation and validation of our LabVantage Laboratory Information Management System (LIMS) is complete in our Philadelphia site! Staff at our Philadelphia site worked together with cross-functional teams in Quality, Operations, IT, CSols, Inc. and LabVantage (vendor) to complete the installation and validation of a highly-functional and GMP compliant LIMS system. Lou Forcellini, site
Frank Tagliaferri, Ph.D., VP of Pharmaceutical Development & GM Drug Development and Delivery recently interviewed our very own, Frank Tagliaferri, Ph.D., VP of Pharmaceutical Development & GM at Pace Analytical® Life Sciences (PLS). After two recent acquisitions, Pace now operates five state-of-the-art facilities, and is well-equipped to handle almost any project regardless of scope or
Pace Analytical® Chief Compliance Officer Appointed to California Environmental Laboratory Technical Advisory Committee Judy Morgan of Pace joins group providing guidance on technical issues involving environmental testing, laboratory accreditation, and evaluation of new technology and methods Minneapolis, MN, December 22, 2020 –Pace Analytical® Services, LLC, a national network of laboratories trusted for scientific expertise and
Summary: In an effort to improve stability and shelf life of a drug, the active ingredients in many therapeutics are typically mixed with a number of other inactive chemicals. The end result of this process, called formulation, is commonly a liquid solution or suspension. However, for certain drugs, which are prone to degradation or aggregation,
On-Demand Webinar Lyophilized Drug Product Development Read More »
Thursday, October 15, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST Event Overview: Determining the polymorphism of a drug—the propensity of a molecule to crystallize in different crystalline arrangements, to form crystalline salts and/or non-salt cocrystals—allows for rational selection of the proper solid form/polymorph for further development. In this webcast, learn about the
Live Webcast: Understanding Polymorphism to De-Risk Drug Development Read More »
ON DEMAND WEBINAR: Pharmaceutical Development of Oligonucleotides Oligonucleotides are an emerging class of DNA and RNA therapeutics that address a number of unmet medical needs. As with many biopharmaceuticals, the complex structure of oligonucleotides makes their large-scale synthesis both challenging and imperfect. A number of impurities are generated during manufacturing, many of which are hard
ON DEMAND WEBINAR: Pharmaceutical Development of Oligonucleotides Read More »